Astaxanthin Phospholipid Joint Pain Supplement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for joint pain associated with osteoarthritis and rheumatoid arthritis have limited effectiveness and often come with side effects, and there is a need for alternative dietary supplements that can effectively alleviate symptoms without the drawbacks of traditional therapies.
Innovation Solution
A dietary supplement composition combining astaxanthin, low molecular weight microbial fermented hyaluronic acid or sodium hyaluronate, and phospholipids, glycolipids, or sphingolipids, formulated into an oral dosage form to treat joint pain, which includes krill or algae-based oils, fish oil-derived products, and roe extracts, enhancing bioavailability and synergistic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional treatments for joint pain are used, then pain relief is achieved, but side effects occur and effectiveness is limited
Solution Approach 1:
The patent uses dietary supplements containing astaxanthin, phospholipids, and hyaluronic acid as alternative treatments that can be consumed and replaced, avoiding the cumulative side effects of traditional long-term pharmaceutical treatments while providing effective pain relief through natural compounds
Solution Approach 2:
The invention combines multiple active ingredients (astaxanthin, phospholipids, hyaluronic acid) in a composite dietary supplement formulation that works synergistically to reduce joint pain and inflammation more effectively than single-ingredient treatments, while maintaining a safe profile without traditional drug side effects
2Quantity of substance
If astaxanthin is combined with phospholipids, then bioavailability is improved, but formulation complexity increases
Solution Approach 1:
Phospholipids serve as intermediary substances that enhance the absorption and bioavailability of astaxanthin in the digestive system, acting as natural carriers that facilitate the transport of this potent antioxidant into the bloodstream and target tissues without requiring complex synthetic delivery systems
Solution Approach 2:
The patent optimizes the ratio and concentration of astaxanthin to phospholipids in the formulation, adjusting these parameters to achieve maximum bioavailability while maintaining a simple, natural formulation that avoids the need for complex manufacturing processes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively alleviates joint pain and inflammation by promoting site repair and immune system modulation, with astaxanthin demonstrating potent anti-inflammatory properties and improved bioavailability when combined with phospholipids, leading to significant reductions in inflammatory markers and improved joint health.
Implementation Method 1
astaxanthin demonstrating potent anti-inflammatory properties and improved bioavailability when combined with phospholipids
Implementation Method 2
astaxanthin demonstrating potent anti-inflammatory properties and improved bioavailability when combined with phospholipids, leading to significant reductions in inflammatory markers
Data Source
AI summary
A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid.